Delhi HC quashes ban on anti-inflammatory drug Ace Proxyvon, faults Centre

The Delhi High Court on Monday set aside the central government’s ban on anti-inflammatory medicine Ace Proxyvon, saying the Centre should have taken the decision of banning the drug only after “due application of mind”. Ace Proxyvon is used for painful rheumatic therapy of ailments such as osteoarthritis, rheumatoid arthritis and ankylosing spondylitis.

In September last year, the government had banned around 328 Fixed Dose Combination (FDC) drugs citing lack of therapeutic justification. FDCs are two or more drugs combined in a fixed ratio into a single dosage form. 

These included painkillers, respiratory and other gastro-intestinal medicines. Following the ban